Denmark’s Leo Pharma Delays IPO Plans Beyond 2026, CEO Says
By Sanne Wass
Leo Pharma A/S is delaying plans for an initial public offering beyond 2026, pushing back a listing it had previously targeted for this year.
This story was published by Bloomberg. Read the full article on their site.
Read the full story at bloomberg.com(opens in a new tab)





